EN
HI
Concord Biotech share price chart
Concord Biotech Share Key Metrics
Volume
3.94 L
Market Cap
15849.35 CR
LTQ@LTP
1@1588.70
ATP
1564.91
Var Margin
20.51 %
Circuit Range
1212-1818
Delivery %
36.71 %
Value
61.72 CR
ASM/GSM
No
Market Lot
1
Summary
CONCORDBIO stock price is ₹1588.7 as of 18 Aug, 2026. The stock intraday movement has stayed between ₹1524.00 and ₹1598.00, while Concord Biotech share price 52 week high low is ₹987.00 & ₹1801.90.
In terms of trading activity, CONCORDBIO share price has recorded a volume of 3,94,396 shares. The Concord Biotech has a market cap of ₹104616204. The stock’s Average Traded Price (ATP) stands at ₹1564.91, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1588.70.
The Concord Biotech upper circuit limit is ₹1818.00 & The Concord Biotech lower circuit limit is ₹1212.00, with a Value of ₹61.72 CR. The Delivery Percentage for the day is 36.71%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Concord Biotech Fundamentals
P/E Ratio
57.5
P/B Ratio
7.64
Div. Yield
0.5
Sector P/E
63.29
Sector P/B
3.31
Sec. Div. Yield
0.51
Concord Biotech Resistance and Support
Pivot 1496.03
Resistance
First Resistance
1554.86
Second Resistance
1594.73
Third Resistance
1653.56
Support
First Support
1456.16
Second Support
1397.33
Third Support
1357.46
Concord Biotech Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 18 2026 | 1532.5 | 1588.7 | 4.86% | 1598 | 1524 |
| Mon Aug 17 2026 | 1451.4 | 1515 | 4.39% | 1535.9 | 1437.19 |
| Fri Aug 14 2026 | 1461.59 | 1451.3 | -0.22% | 1461.59 | 1428 |
Concord Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Concord Biotech News
Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Concord Biotech made the audio recording of its Q1 FY27 earnings call available on its website. This allows investors to access the full discussion from the call regarding the company's unaudited results.
Aug 03 2026 18:08:38
Concord Biotech Ltd - 543960 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Friday, July 31, 2026 - Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Concord Biotech reported robust Q1 FY27 consolidated financial results. Revenue increased 26.2% YoY to ₹257.49 crore, and net profit grew 31.0% YoY to ₹57.70 crore, with EPS at ₹5.52.
Jul 31 2026 18:14:06
Concord Biotech Management
| Name | Position |
|---|---|
| Sudhir Vaid | Chairman & Managing Director |
| Ankur Vaid | Joint Managing Director & CEO |
Concord Biotech Similar Stocks
Natco Pharma Ltd.
895.75
5.95 (0.67%)
Shilpa Medicare Ltd.
813.00
3.70 (0.46%)
Dr. Agarwal's Health Care Ltd.
498.90
-2.70 (0.54%)
Vijaya Diagnostic Centre Ltd.
1509.00
2.40 (0.16%)
Marksans Pharma Ltd.
327.75
-3.70 (1.12%)
Rainbow Children's Medicare Ltd.
1463.80
-14.70 (0.99%)
Jubilant Pharmova Ltd.
867.50
0.55 (0.06%)
CORONA Remedies Ltd.
2126.80
13.70 (0.65%)
Alivus Life Sciences Ltd.
1403.70
9.30 (0.67%)
Concord Biotech FAQs
The Buying Price of Concord Biotech share is 1588.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Concord Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Concord Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Concord Biotech shares is 57.5. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Concord Biotech shares is 7.64. Useful to assess the stock's value relative to its book value.
To assess Concord Biotech’s valuation compare Sector P/E, P/B which are 63.29 & 3.31 with sector averages, along with growth rates and financial metrics.
The Market Cap of Concord Biotech is 15849.35 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Concord Biotech share price is 1801.90 & 987.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Concord Biotech belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in CONCORDBIO
Or Download Choice FinX App
Invest in CONCORDBIO
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade